---
title: "Abbott Laboratories Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293383750.md"
description: "Abbott Laboratories (ABT) shares fell 1.96% to $99.67 on Tuesday, underperforming the broader market and key competitors like Johnson & Johnson, Pfizer, and Merck. This decline ended a four-day winning streak. The stock remains 27.51% below its 52-week high of $137.49. Trading volume was lower than the 50-day average."
datetime: "2026-07-21T20:34:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293383750.md)
  - [en](https://longbridge.com/en/news/293383750.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293383750.md)
generator: "portal-rs"
---

# Abbott Laboratories Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories (ABT) shed 1.96% to $99.67 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.

The stock's fall snapped a four-day winning streak.

Abbott Laboratories closed 27.51% short of its 52-week high of $137.49, which the company reached on September 22nd.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.72% to $250.61, Pfizer Inc. (PFE) rose 0.77% to $24.94, and Merck & Co. Inc. (MRK) rose 1.50% to $126.26.

Trading volume (10.3 M) remained 3.2 million below its 50-day average volume of 13.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-21-26 1634ET

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Xcel Wealth Management LLC Cuts Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/296700328.md)
- [Heritage Trust Co Increases Stock Position in Abbott Laboratories $ABT](https://longbridge.com/en/news/297292932.md)
- [Edmond DE Rothschild Holding S.A. Acquires Shares of 154,431 Abbott Laboratories $ABT](https://longbridge.com/en/news/297417415.md)
- [Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes | ABT Stock News](https://longbridge.com/en/news/296948033.md)
- [Did Abbott’s Q2 Beat and Profit Hike Just Shift Abbott Laboratories’ (ABT) Investment Narrative?](https://longbridge.com/en/news/296546525.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**